M. Krantz

Emerging Causes of Drug-Induced Anaphylaxis: A Review of Anaphylaxis-Associated Reports in the FDA Adverse Event Reporting System (FAERS).

E. Phillips, C. Stone, Matthew S. Krantz, 2020, The journal of allergy and clinical immunology. In practice.

The clinical application of genetic testing in DILI, are we there yet?

Elizabeth J. Phillips, Madeline E Marks, M. Krantz, 2024, Clinical liver disease.

Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis.

D. Golden, D. Chu, M. Greenhawt, 2022, JAMA internal medicine.

Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions.

M. Pirmohamed, M. Mockenhaupt, Andrew Gibson, 2023, The Journal of allergy and clinical immunology.

Glycolysis: An early marker for vancomycin‐specific T‐cell activation

M. Pirmohamed, D. Naisbitt, Matthew S. Krantz, 2024, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Clinical Phenotypes of Immediate First-Dose Reactions to mRNA COVID-19: A Multicenter Latent Class Analysis

M. Krantz, Lacey B. Robinson, 2022 .

Clinical Phenotypes of Immediate First-Dose Reactions to mRNA COVID-19: A Multicenter Latent Class Analysis

M. Krantz, Lacey B. Robinson, 2022 .